Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Current Association for the Advancement of Blood & Biotherapies (AABB) standards require transfusion services to have a policy on Rh immune globulin (RhIG) immunoprophylaxis for when RhD-negative patients are exposed to RhD-positive red cells. This is a survey of AABB-accredited transfusion services in the United States (US) regarding institutional policies and practices on RhIG immunoprophylaxis after RhD-negative patients receive RhD-positive (i.e., RhD-incompatible) packed red blood cell (pRBC) and platelet transfusions.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Transfusion

Title: Transfusion

Publisher: Wiley

ISSN (Electronic): 1537-2995

ISSN (Print): 0041-1132

Publication date (Electronic): May 2024

Volume: 64

Issue: 5

Affiliations

[1 ] Department of Laboratory Medicine and Pathology, Center for Regenerative Biotherapeutics, Mayo Clinic, Rochester, Minnesota, USA.

[2 ] Department of Pathology, University of California San Diego, San Diego, California, USA.

[3 ] Pathology and Laboratory Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA.

[4 ] Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

[5 ] Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

[6 ] ImpactLife, Davenport, Iowa, USA.

[7 ] Department of Pathology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

[8 ] Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.

[9 ] Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

[10 ] Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

[11 ] Department of Pathology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

[12 ] Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA.

Article

DOI: 10.1111/trf.17812

PubMed ID: 38534065

SO-VID: 4ac4d0c1-0522-4591-8ff7-9d88d92c988b

History

Keywords: RhIG,alloimmunization,anti‐D,immunoprophylaxis,transfusion

Data availability:

Keywords: RhIG, alloimmunization, anti‐D, immunoprophylaxis, transfusion

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.